Evidence map›Paper›PMID 26562499›Full record

ArticleAmerican journal of respiratory cell and molecular biology2016

A Rhesus Macaque Model of Pulmonary Nontuberculous Mycobacterial Disease.

Kevin Winthrop, Andrea Rivera, Flora Engelmann, Sasha Rose, Anne Lewis, Jennifer Ku, Luiz Bermudez, Ilhem Messaoudi

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in American journal of respiratory cell and molecular biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07094711 (Safety, Immunogenicity, and Efficacy of Therapeutic Mycobacterium Bovis BCG in Patients With Mycobacterium Avium Complex Lung Disease), which is not on this map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07094711 phase2recruitingnot on this mapstarted 2026, after this paper: background citation

Safety, Immunogenicity, and Efficacy of Therapeutic Mycobacterium Bovis BCG in Patients With Mycobacterium Avium Complex Lung Disease (BOOST)

TypeinterventionalSponsorUniversity of VirginiaRan2026 to 2028Enrolled48ConditionsMycobacterium Avium-intracellulare Infection, Mycobacterium Infections, NontuberculousArmsMycobacterium bovis Bacillus Calmette Guerin (BCG) vaccine, preservative-free saline
3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Immunity AgainstVaccines · 2025
    Article
  5. Article
  6. Assays for AssessingPathogens (Basel, Switzerland) · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. BCG Vaccination InducesFrontiers in immunology · 2019
    Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Kevin Winthrop1 Division of Infectious Diseases, Oregon Health and Science University, Portland, Oregon.
Andrea Rivera2 Division of Biomedical Sciences, University of California, Riverside, California.
Flora Engelmann2 Division of Biomedical Sciences, University of California, Riverside, California.
Sasha Rose3 Department of Microbiology, Oregon State University, Corvallis, Oregon.
Anne Lewis4 Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon.
Jennifer Ku1 Division of Infectious Diseases, Oregon Health and Science University, Portland, Oregon.
Luiz Bermudez3 Department of Microbiology, Oregon State University, Corvallis, Oregon.
Ilhem Messaoudi2 Division of Biomedical Sciences, University of California, Riverside, California.
Oregon Health & Science University · USOregon National Primate Research Center · USOregon State University · USUniversity of California, Riverside · US

Funding

Upgrade of confocal microscopy at the Oregon National Primate Research CenterP51OD011092 · OD · OREGON HEALTH & SCIENCE UNIVERSITY · PI Bonnie J. Nagel · 2012 to 2026
$203.9M
Genes Associated with Mycobacterium avium PathogenesisR01AI043199 · NIAID · OREGON STATE UNIVERSITY · PI BERMUDEZ, LUIZ EDUARDO · 1999 to 2014
$4.3M
NIAID NIH HHS AI043199NIAID NIH HHS R01 AI043199NIH HHS 8P51 OD011092-53NIH HHS P51 OD011092
6 · The paper itself

Abstract

In this study, we sought to develop a nonhuman primate model of pulmonary Mycobacterium avium complex (MAC) disease. Blood and bronchoalveolar lavage fluid were collected from three female rhesus macaques infected intrabronchially with escalating doses of M. avium subsp. hominissuis. Immunity was determined by measuring cytokine levels, lymphocyte proliferation, and antigen-specific responses. Disease progression was monitored clinically and microbiologically with serial thoracic radiographs, computed tomography scans, and quantitative mycobacterial cultures. The animal subjected to the highest inoculum showed evidence of chronic pulmonary MAC disease. Therefore, rhesus macaques could provide a robust model in which to investigate host-pathogen interactions during MAC infection.

Indexed as

AnimalsAntibodies, BacterialBacterial LoadBiopsyBronchoalveolar Lavage FluidCell ProliferationChronic DiseaseCytokinesDisease Models, AnimalFemaleImmunoglobulin GLungLymphocyte ActivationMacaca mulattaMycobacterium avium ComplexMycobacterium avium-intracellulare InfectionAntibodies, BacterialCytokinesImmunoglobulin GgranulomamacaqueMycobacterium aviumnontuberculous mycobacteriaT cells

Identifiers

PMID26562499
PMCPMC4821046
OpenAlexW2179885351

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.